Institut Servier de Médecine Translationnelle

Servier is a global independent pharmaceutical group governed by a non-profit foundation, headquartered in Suresnes, France. The company focuses on five main therapeutic areas: oncology, cardiovascular and metabolic diseases, neuroscience, and immuno-inflammation. Its research efforts are centered on translational medicine to accelerate the transition from laboratory discovery to patient treatment, particularly through its flagship R&D center at Paris-Saclay. Servier is known for its significant investment in R&D, reinvesting over 20% of its commercial revenue into research. The group operates in over 150 countries and maintains a diverse portfolio of innovative medicines and high-quality generics.